Photocure ASA: Notification of primary insider transaction
Oslo, Norway, 31 October 2025: Board member Neal Shore has acquired 13,500 shares at a price per share of NOK 55,21. Primary insider notification pursuant to the market abuse regulation article 19 is attached.
For further information, please contact:
Photocure
CFO Erik Dahl
Tel: +47 450 55 000
Email: [email protected]
About Photocure ASA
Photocure: The Bladder Cancer Company delivers transformative solutions to improve the lives of bladder cancer patients. Our unique technology, making cancer cells glow bright pink, has led to better health outcomes for patients worldwide. Photocure is headquartered in Oslo, Norway and listed on the Oslo Stock Exchange (OSE: PHO). For more information, please visit us at www.photocure.com/news
All trademarks mentioned in this release are protected by law and are registered trademarks of Photocure ASA.
This information is subject to the disclosure requirements pursuant to the market abuse regulation article 19 and 5-12 of the Norwegian Securities Trading Act.